191 related articles for article (PubMed ID: 16020756)
1. Prevention of cardiac hypertrophy by atorvastatin in a transgenic rabbit model of human hypertrophic cardiomyopathy.
Senthil V; Chen SN; Tsybouleva N; Halder T; Nagueh SF; Willerson JT; Roberts R; Marian AJ
Circ Res; 2005 Aug; 97(3):285-92. PubMed ID: 16020756
[TBL] [Abstract][Full Text] [Related]
2. Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy.
Patel R; Nagueh SF; Tsybouleva N; Abdellatif M; Lutucuta S; Kopelen HA; Quinones MA; Zoghbi WA; Entman ML; Roberts R; Marian AJ
Circulation; 2001 Jul; 104(3):317-24. PubMed ID: 11457751
[TBL] [Abstract][Full Text] [Related]
3. Resolution of established cardiac hypertrophy and fibrosis and prevention of systolic dysfunction in a transgenic rabbit model of human cardiomyopathy through thiol-sensitive mechanisms.
Lombardi R; Rodriguez G; Chen SN; Ripplinger CM; Li W; Chen J; Willerson JT; Betocchi S; Wickline SA; Efimov IR; Marian AJ
Circulation; 2009 Mar; 119(10):1398-407. PubMed ID: 19255346
[TBL] [Abstract][Full Text] [Related]
4. HMG CoA reductase inhibition and left ventricular mass in hypertrophic cardiomyopathy: a randomized placebo-controlled pilot study.
Bauersachs J; Störk S; Kung M; Waller C; Fidler F; Hoyer C; Frantz S; Weidemann F; Ertl G; Angermann CE
Eur J Clin Invest; 2007 Nov; 37(11):852-9. PubMed ID: 17973781
[TBL] [Abstract][Full Text] [Related]
5. Evolution of expression of cardiac phenotypes over a 4-year period in the beta-myosin heavy chain-Q403 transgenic rabbit model of human hypertrophic cardiomyopathy.
Nagueh SF; Chen S; Patel R; Tsybouleva N; Lutucuta S; Kopelen HA; Zoghbi WA; Quiñones MA; Roberts R; Marian AJ
J Mol Cell Cardiol; 2004 May; 36(5):663-73. PubMed ID: 15135661
[TBL] [Abstract][Full Text] [Related]
6. Atorvastatin improves endothelial function and cardiac performance in patients with dilated cardiomyopathy: the role of inflammation.
Liu M; Wang F; Wang Y; Jin R
Cardiovasc Drugs Ther; 2009 Oct; 23(5):369-76. PubMed ID: 19636689
[TBL] [Abstract][Full Text] [Related]
7. Additive beneficial effects of amlodipine and atorvastatin in reversing advanced cardiac hypertrophy in elderly spontaneously hypertensive rats.
Lu JC; Cui W; Zhang HL; Liu F; Han M; Liu DM; Yin HN; Zhang K; Du J
Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1110-9. PubMed ID: 19413592
[TBL] [Abstract][Full Text] [Related]
8. Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure.
Sola S; Mir MQ; Lerakis S; Tandon N; Khan BV
J Am Coll Cardiol; 2006 Jan; 47(2):332-7. PubMed ID: 16412856
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory effects of atorvastatin improve left ventricular function in experimental diabetic cardiomyopathy.
Van Linthout S; Riad A; Dhayat N; Spillmann F; Du J; Dhayat S; Westermann D; Hilfiker-Kleiner D; Noutsias M; Laufs U; Schultheiss HP; Tschöpe C
Diabetologia; 2007 Sep; 50(9):1977-1986. PubMed ID: 17589825
[TBL] [Abstract][Full Text] [Related]
10. Atorvastatin and cardiac hypertrophy and function in hypertrophic cardiomyopathy: a pilot study.
Nagueh SF; Lombardi R; Tan Y; Wang J; Willerson JT; Marian AJ
Eur J Clin Invest; 2010 Nov; 40(11):976-83. PubMed ID: 20629707
[TBL] [Abstract][Full Text] [Related]
11. Atorvastatin and myocardial reperfusion injury: new pleiotropic effect implicating multiple prosurvival signaling.
Efthymiou CA; Mocanu MM; Yellon DM
J Cardiovasc Pharmacol; 2005 Mar; 45(3):247-52. PubMed ID: 15725950
[TBL] [Abstract][Full Text] [Related]
12. Mitogen-activated protein kinases (p38 and c-Jun NH2-terminal kinase) are differentially regulated during cardiac volume and pressure overload hypertrophy.
Sopontammarak S; Aliharoob A; Ocampo C; Arcilla RA; Gupta MP; Gupta M
Cell Biochem Biophys; 2005; 43(1):61-76. PubMed ID: 16043884
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin improves microenvironment to enhance the beneficial effects of BMSCs therapy in a rabbit model of acute myocardial infarction.
Qu Z; Xu H; Tian Y; Jiang X
Cell Physiol Biochem; 2013; 32(2):380-9. PubMed ID: 23988469
[TBL] [Abstract][Full Text] [Related]
14. Antiarrhythmic effect of atorvastatin on autoimmune myocarditis is mediated by improving myocardial repolarization.
Tang Q; Huang J; Qian H; Chen L; Wang T; Wang H; Shen D; Wu H; Xiong R
Life Sci; 2007 Jan; 80(7):601-8. PubMed ID: 17217967
[TBL] [Abstract][Full Text] [Related]
15. [Atorvastatin induced increase in homologous angiotensin I converting enzyme (ACE2) mRNA is associated to decreased fibrosis and decreased left ventricular hypertrophy in a rat model of diabetic cardiomyopathy].
Aguilar C; Ventura F; Rodríguez-Delfín L
Rev Peru Med Exp Salud Publica; 2011 Jun; 28(2):264-72. PubMed ID: 21845306
[TBL] [Abstract][Full Text] [Related]
16. Original Research: Atorvastatin prevents rat cardiomyocyte hypertrophy induced by parathyroid hormone 1-34 associated with the Ras-ERK signaling.
Liu X; Zou C; Yu C; Xie R; Sui M; Mu S; Li L; Zhao S
Exp Biol Med (Maywood); 2016 Oct; 241(16):1745-50. PubMed ID: 27190264
[TBL] [Abstract][Full Text] [Related]
17. Ranolazine Prevents Phenotype Development in a Mouse Model of Hypertrophic Cardiomyopathy.
Coppini R; Mazzoni L; Ferrantini C; Gentile F; Pioner JM; Laurino A; Santini L; Bargelli V; Rotellini M; Bartolucci G; Crocini C; Sacconi L; Tesi C; Belardinelli L; Tardiff J; Mugelli A; Olivotto I; Cerbai E; Poggesi C
Circ Heart Fail; 2017 Mar; 10(3):. PubMed ID: 28255011
[TBL] [Abstract][Full Text] [Related]
18. Atorvastatin attenuates mitochondrial toxin-induced striatal degeneration, with decreasing iNOS/c-Jun levels and activating ERK/Akt pathways.
Lee ST; Chu K; Park JE; Hong NH; Im WS; Kang L; Han Z; Jung KH; Kim MW; Kim M
J Neurochem; 2008 Mar; 104(5):1190-200. PubMed ID: 17976163
[TBL] [Abstract][Full Text] [Related]
19. Atorvastatin inhibits myocardial cell apoptosis in a rat model with post-myocardial infarction heart failure by downregulating ER stress response.
Song XJ; Yang CY; Liu B; Wei Q; Korkor MT; Liu JY; Yang P
Int J Med Sci; 2011; 8(7):564-72. PubMed ID: 21960749
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic association of atorvastatin and insulin in cardiac ischemia: study in a model of type 2 diabetes with hyperlipidemia.
Matafome P; Monteiro P; Nunes E; Louro T; Amaral C; Moedas AR; Gonçalves L; Providência L; Seiça R
Pharmacol Res; 2008; 58(3-4):208-14. PubMed ID: 18692137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]